HARP
Price:
$23.01
Market Cap:
$865.08M
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic c...[Read more]
Industry
Biotechnology
IPO Date
2019-02-08
Stock Exchange
NASDAQ
Ticker
HARP
According to Harpoon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 861.85M. This represents a change of -45240.06% compared to the average of -1909269.44 of the last 4 quarters.
The mean historical Enterprise Value of Harpoon Therapeutics, Inc. over the last ten years is 342.50M. The current 861.85M Enterprise Value has changed 25.06% with respect to the historical average. Over the past ten years (40 quarters), HARP's Enterprise Value was at its highest in in the December 2017 quarter at 1.25B. The Enterprise Value was at its lowest in in the March 2023 quarter at -18275651.76.
Average
342.50M
Median
211.17M
Minimum
-11528445.82
Maximum
1.28B
Discovering the peaks and valleys of Harpoon Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 137.73%
Maximum Annual Enterprise Value = 1.28B
Minimum Annual Increase = -105.46%
Minimum Annual Enterprise Value = -11528445.82
Year | Enterprise Value | Change |
---|---|---|
2022 | -11528445.82 | -105.46% |
2021 | 211.17M | -48.26% |
2020 | 408.18M | 124.96% |
2019 | 181.45M | -22.22% |
2018 | 233.28M | 137.73% |
2017 | 98.13M | -92.31% |
The current Enterprise Value of Harpoon Therapeutics, Inc. (HARP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
202.61M
5-year avg
204.51M
10-year avg
342.50M
Harpoon Therapeutics, Inc.’s Enterprise Value is greater than Passage Bio, Inc. (33.56M), greater than Black Diamond Therapeutics, Inc. (123.50M), greater than TCR2 Therapeutics Inc. (79.12M), greater than Alector, Inc. (185.51M), greater than Stoke Therapeutics, Inc. (467.23M), greater than Homology Medicines, Inc. (-103303255.00), less than Adaptimmune Therapeutics plc (0), greater than Revolution Medicines, Inc. (58.35M), less than Atreca, Inc. (7.90B), greater than null (-8620212.00),
Company | Enterprise Value | Market cap |
---|---|---|
33.56M | $40.03M | |
123.50M | $123.92M | |
79.12M | $58.11M | |
185.51M | $188.03M | |
467.23M | $614.95M | |
-103303255.00 | $3.02M | |
0 | $150.46M | |
58.35M | $8.01B | |
7.90B | $3.57M | |
-8620212.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harpoon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Harpoon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Harpoon Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Harpoon Therapeutics, Inc. (HARP)?
What is the 3-year average Enterprise Value for Harpoon Therapeutics, Inc. (HARP)?
What is the 5-year average Enterprise Value for Harpoon Therapeutics, Inc. (HARP)?
How does the current Enterprise Value for Harpoon Therapeutics, Inc. (HARP) compare to its historical average?